It's Not That Simple

Thanks to a new test, checking for genetic abnormalities in a fetus is easier and less invasive — but there's a downside, says Nature News' Erika Check Hayden. Sequenom's new MaterniT21 Down syndrome test requires only a small sample of the mother's blood, and is only one of several similar tests expected to hit the market soon, Hayden says. While such tests spare women from amniocentesis or other invasive procedures, doctors say they pose other problems, Hayden says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.